Company Filing History:
Years Active: 2004
Title: The Innovations of José Ignacio Escamilla
Introduction
José Ignacio Escamilla is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory bowel disease. His innovative work has led to the development of a unique sodium salt compound that holds promise for medical applications.
Latest Patents
José Ignacio Escamilla holds a patent for the sodium salt of an azo derivative of 5-aminosalicylic acid. This invention relates to the sodium salt of (Z)-2-hydroxy-5-([4-[3-[4-[(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)methyl]-1-piperidinyl]-3-oxo-1-phenyl-1-propenyl]phenyl]azo]benzoic acid. The patent also covers pharmaceutical compositions containing this compound, a procedure for its preparation, and its use in manufacturing medicaments aimed at treating or preventing inflammatory bowel disease.
Career Highlights
José Ignacio Escamilla is associated with J. Uriach & Cia, S.A., a company known for its commitment to pharmaceutical innovation. His work at the company has been instrumental in advancing research and development in the field of medicinal chemistry.
Collaborations
Throughout his career, José has collaborated with esteemed colleagues such as Elena Carceller and Jorge Salas Solana. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
José Ignacio Escamilla's contributions to pharmaceutical innovation exemplify the impact of dedicated research in addressing medical challenges. His patent for the sodium salt of an azo derivative of 5-aminosalicylic acid represents a significant advancement in the treatment of inflammatory bowel disease.